D009837DisordersC04.557.465.625.600.380.590C04.557.470.670.380.590C04.557.580.625.600.380.59012450.975326Oligodendrogliomaprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson28472509Thomas AA, Abrey LE, Terziev R, Raizer J, Martinez NL, Forsyth P, Paleologos N, Matasar M, Sauter CS, Moskowitz C, Nimer SD, DeAngelis LM, Kaley T, Grimm S, Louis DN, Cairncross JG, Panageas KS, Briggs S, Faivre G, Mohile NA, Mehta J, Jonsson P, Chakravarty D, Gao J, Schultz N, Brennan CW, Huse JT, Omuro ANeuro-oncologyMulticenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma. Neuro Oncol. 2017 Oct 01; 19(10):1380-1390.Neuro Oncol2017-10-01T00:00:002017Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.31262396Ravanpay AC, Gabikian P, Marshall D, Williams JR, Huber B, Silbergeld DLClinical neuropathologySynchronous identification of a dysembryoplastic neuroepithelial tumor (DNET) and an oligodendroglioma in a patient: A case report. Clin Neuropathol. 2019 Nov/Dec; 38(6):269-275.Clin Neuropathol2019-11-01T00:00:002019Synchronous identification of a dysembryoplastic neuroepithelial tumor (DNET) and an oligodendroglioma in a patient: A case report.Mei-YinPolley2mF5BK0ZHPX5k2lgLlPt+2z5/syyp7BaZQ==Mei-Yin Polley41.7886000000000087.598699999999993904Polley, Mei-YinAssociate ProfessorMedicine-Hematology and OncologyNeurological SurgeryPublic Health Scienceshttp://pbhs.uchicago.eduPHS graduate programhttps://health.uchicago.edu/Department of Public Health Scienceshttps://www.uchicagomedicine.org/find-a-physician/physician/peter-warnkeLearn more about this provider...2.056550.027648912research area of0.8846230.017649553subject area forSurgeryUniversity of ChicagoNinaPaleologosNina Paleologos41.78927490000000-87.601250000000001234Paleologos, NinaPatrikGabikianPatrik Gabikian41.78927490000000-87.601250000000002162Gabikian, PatrikAssistant ProfessorKenneth S.Cohen3GFmA6QbSMzMknJtY0fp/Cv/+94=Kenneth S. Cohen41.78927490000000-87.601250000000002167Cohen, Kenneth S.Associate ProfessorPeter ChristianWarnkex3VoGa8eHMzMknJtY0fp/Cv/+94=Peter Christian Warnke41.78927490000000-87.601250000000002372Warnke, Peter ChristianProfessor35731991Lassman AB, Hoang-Xuan K, Polley MC, Brandes AA, Cairncross JG, Kros JM, Ashby LS, Taphoorn MJB, Souhami L, Dinjens WNM, Laack NN, Kouwenhoven MCM, Fink KL, French PJ, Macdonald DR, Lacombe D, Won M, Gorlia T, Mehta MP, van den Bent MJJournal of clinical oncology : official journal of the American Society of Clinical OncologyJoint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors. J Clin Oncol. 2022 08 10; 40(23):2539-2545.J Clin Oncol2022-06-22T00:00:002022Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.true1true1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professor24997140Panageas KS, Reiner AS, Iwamoto FM, Cloughesy TF, Aldape KD, Rivera AL, Eichler AF, Louis DN, Paleologos NA, Fisher BJ, Ashby LS, Cairncross JG, Urgoiti GB, Wen PY, Ligon KL, Schiff D, Robins HI, Rocque BG, Chamberlain MC, Mason WP, Weaver SA, Green RM, Kamar FG, Abrey LE, DeAngelis LM, Jhanwar SC, Rosenblum MK, Lassman ABNeuro-oncologyRecursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors. Neuro Oncol. 2014 Nov; 16(11):1541-6.Neuro Oncol2014-07-04T00:00:002014Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors.24805856Rodriguez FJ, Tihan T, Lin D, McDonald W, Nigro J, Feuerstein B, Jackson S, Cohen K, Burger PCThe American journal of surgical pathologyClinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients. Am J Surg Pathol. 2014 Aug; 38(8):1058-70.Am J Surg Pathol2014-08-01T00:00:002014Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients.